3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide

C30H29ClN6O5 — CID 90365272

IUPAC3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide
SMILESCCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OCCC(=O)Nc3cccc(O)c3O)ccc2-n2c(C)nnc21
InChIInChI=1S/C30H29ClN6O5/c1-3-32-27(40)16-23-30-36-35-17(2)37(30)24-12-11-20(15-21(24)28(34-23)18-7-9-19(31)10-8-18)42-14-13-26(39)33-22-5-4-6-25(38)29(22)41/h4-12,15,23,38,41H,3,13-14,16H2,1-2H3,(H,32,40)(H,33,39)/t23-/m0/s1
InChIKeyRQGICDASQCACLO-QHCPKHFHSA-N
MW589.05 g/mol
LogP4.47
Rot. Bonds9

About 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide

3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide (PubChem CID 90365272) has the molecular formula C30H29ClN6O5 and a molecular weight of 589.05 g/mol. Its IUPAC name is 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide.

Molecular Properties

Compound Name3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide
PubChem CID90365272
Molecular FormulaC30H29ClN6O5
Molecular Weight589.05 g/mol
Exact Mass588.19
IUPAC Name3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide
SMILESCCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OCCC(=O)Nc3cccc(O)c3O)ccc2-n2c(C)nnc21
InChIInChI=1S/C30H29ClN6O5/c1-3-32-27(40)16-23-30-36-35-17(2)37(30)24-12-11-20(15-21(24)28(34-23)18-7-9-19(31)10-8-18)42-14-13-26(39)33-22-5-4-6-25(38)29(22)41/h4-12,15,23,38,41H,3,13-14,16H2,1-2H3,(H,32,40)(H,33,39)/t23-/m0/s1
InChIKeyRQGICDASQCACLO-QHCPKHFHSA-N
XLogP4.47
TPSA150.96 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds9
Heavy Atoms42
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500589.05
LogP ≤ 54.47
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'catechol_A(92)', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}

Analyze 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide?
The IUPAC name of 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide (CID 90365272) is 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide.
What is the SMILES notation for 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide?
The canonical SMILES for 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide is CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OCCC(=O)Nc3cccc(O)c3O)ccc2-n2c(C)nnc21.
What is the InChIKey of 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide?
The InChIKey is RQGICDASQCACLO-QHCPKHFHSA-N. The full InChI is InChI=1S/C30H29ClN6O5/c1-3-32-27(40)16-23-30-36-35-17(2)37(30)24-12-11-20(15-21(24)28(34-23)18-7-9-19(31)10-8-18)42-14-13-26(39)33-22-5-4-6-25(38)29(22)41/h4-12,15,23,38,41H,3,13-14,16H2,1-2H3,(H,32,40)(H,33,39)/t23-/m0/s1.
What are the key properties of 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide?
3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide has a molecular weight of 589.05 g/mol, XLogP of 4.47, 9 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]-N-(2,3-dihydroxyphenyl)propanamide is sourced from PubChem (CID 90365272), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).